疫苗诱导免疫及抗结核保护中的性别差异
研究用BCG及两种重组疫苗VPM1002和BCGΔBCG1419c免疫雌雄C57BL/6小鼠,评估对结核分枝杆菌HN878的保护。三种疫苗在雌鼠中效力相当,但BCG不能保护雄鼠免于Mtb所致死亡,重组疫苗在雄鼠中保护更优。BCGΔBCG1419c增强雄鼠淋巴结CD8 T细胞和B细胞回忆应答并减轻肺部炎症。
要点
- BCG对雌鼠有保护,但对雄鼠不能防止Mtb致死。
- 重组疫苗VPM1002和BCGΔBCG1419c在雄鼠中保护优于BCG。
- BCGΔBCG1419c增强雄鼠CD8 T细胞和B细胞回忆应答。
核心结论
- 疫苗诱导的免疫和保护效果存在性别差异,BCG对雄鼠保护不足而重组疫苗更优。
研究设计与样本
- 研究用BCG及重组疫苗VPM1002、BCGΔBCG1419c免疫雌雄C57BL/6小鼠,攻击Mtb HN878。
主要发现
- 三种疫苗在雌鼠中效力相当。
- BCG不能保护雄鼠免于Mtb诱导的死亡。
- 重组疫苗在雄鼠中提供改善的保护。
- BCGΔBCG1419c而非BCG增强雄鼠疫苗引流淋巴结CD8 T细胞和B细胞回忆应答。
- BCGΔBCG1419c减少雄鼠Mtb攻击后肺部炎症。
临床怎么用
- 未来结核疫苗研究应将性别作为生物学变量以优化接种策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Tuberculosis (TB) remains a leading global cause of death, with approximately 1.3 million fatalities annually. While males are more susceptible to TB, the underlying immune differences and their impact on vaccine efficacy are not fully understood. In this study, we vaccinated male and female C57BL/6 mice with BCG and 2 recombinant derivatives, VPM1002 and BCGΔBCG1419c, and assessed their protection against Mycobacterium tuberculosis (Mtb) HN878. While all 3 vaccines showed comparable efficacy in females, BCG did not protect males from Mtb-induced death. Instead, recombinant vaccines provided improved protection in males. Vaccination of males with BCGΔBCG1419c, but not BCG, enhanced CD8 T-cell and B-cell recall responses in vaccine-draining lymph nodes, and reduced lung inflammation after Mtb challenge. These findings underscore the impact of sex differences on vaccine efficacy and suggest that future research should consider sex as a biological variable to optimize TB vaccination strategies.
引用
- Harikumar Parvathy G, Hertz D, Bhandiwad D, et al. Sex Differences in Vaccine-Induced Immunity and Protection Against Mycobacterium tuberculosis. J Infect Dis. 2025. PMID: 40569757. doi:10.1093/infdis/jiaf277
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。